🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
61,65 USD
Máx. histórico
2.925,00
12011 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,89%
Rango 52 semanas
37,06 – 95,49
Variación hoy
+3,56%
Cierre anterior
59,53
Rango de hoy
59,06 – 61,99
Volumen hoy
1.487.357
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,86%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 16 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/03/2012 | 5,35 | 5,41 | 5,35 | 5,39 | +0,67% | 1,12% | 11.200 |
| 01/03/2012 | 5,40 | 5,40 | 5,31 | 5,35 | -0,74% | 1,67% | 31.300 |
| 29/02/2012 | 5,59 | 5,59 | 5,35 | 5,39 | +0,56% | 4,29% | 101.900 |
| 28/02/2012 | 5,25 | 5,50 | 5,25 | 5,36 | +2,29% | 4,76% | 53.600 |
| 27/02/2012 | 5,25 | 5,29 | 5,18 | 5,24 | +0,40% | 2,10% | 7.100 |
| 24/02/2012 | 5,17 | 5,22 | 5,15 | 5,22 | +1,34% | 1,35% | 8.200 |
| 23/02/2012 | 5,16 | 5,16 | 5,15 | 5,15 | -0,39% | 0,19% | 13.900 |
| 22/02/2012 | 5,15 | 5,22 | 5,15 | 5,17 | +0,19% | 1,36% | 9.100 |
| 21/02/2012 | 5,25 | 5,33 | 5,15 | 5,16 | +1,18% | 3,43% | 14.700 |
| 17/02/2012 | 5,15 | 5,19 | 5,05 | 5,10 | -1,73% | 2,64% | 32.200 |
| 16/02/2012 | 5,16 | 5,20 | 5,12 | 5,19 | -0,19% | 1,55% | 24.600 |
| 15/02/2012 | 5,15 | 5,20 | 5,15 | 5,20 | +1,05% | 0,97% | 8.500 |
| 14/02/2012 | 5,26 | 5,29 | 5,10 | 5,15 | -1,98% | 3,59% | 12.400 |
| 13/02/2012 | 5,20 | 5,32 | 5,17 | 5,25 | +0,96% | 2,96% | 10.700 |
| 10/02/2012 | 5,35 | 5,36 | 5,11 | 5,20 | -2,26% | 4,64% | 6.900 |
| 09/02/2012 | 5,20 | 5,34 | 5,14 | 5,32 | +2,90% | 3,84% | 17.600 |
| 08/02/2012 | 5,16 | 5,35 | 5,16 | 5,17 | +1,37% | 3,68% | 18.600 |
| 07/02/2012 | 5,06 | 5,20 | 5,06 | 5,10 | +0,79% | 2,77% | 16.200 |
| 06/02/2012 | 5,03 | 5,16 | 5,03 | 5,06 | +0,20% | 2,50% | 7.100 |
| 03/02/2012 | 5,15 | 5,20 | 5,05 | 5,05 | -1,27% | 2,91% | 11.900 |
| 02/02/2012 | 5,07 | 5,21 | 5,07 | 5,12 | +1,29% | 2,76% | 12.400 |
| 01/02/2012 | 4,72 | 5,24 | 4,71 | 5,05 | +6,77% | 11,23% | 19.600 |
| 31/01/2012 | 4,97 | 4,99 | 4,73 | 4,73 | -3,01% | 5,23% | 13.900 |
| 30/01/2012 | 4,90 | 4,90 | 4,75 | 4,88 | -0,08% | 3,06% | 19.500 |
| 27/01/2012 | 5,00 | 5,09 | 4,82 | 4,88 | -2,38% | 5,40% | 16.800 |
| 26/01/2012 | 5,10 | 5,14 | 4,93 | 5,00 | -3,29% | 4,12% | 15.200 |
| 25/01/2012 | 5,12 | 5,20 | 5,08 | 5,17 | -1,90% | 2,44% | 36.100 |
| 24/01/2012 | 5,38 | 5,38 | 5,15 | 5,27 | -2,23% | 4,28% | 14.700 |
| 23/01/2012 | 5,39 | 5,39 | 5,10 | 5,39 | +0,00% | 5,31% | 19.700 |
| 20/01/2012 | 5,35 | 5,39 | 5,12 | 5,39 | +0,75% | 5,14% | 11.300 |